The $80M Case for AI Governance

Health systems are growing investments in AI to address margin pressure, workforce shortages, and patient outcomes. Yet many still struggle to convert AI activity into measurable enterprise value. Promising tools remain stuck in approval queues, generative AI deployments often fail to deliver expected impact, and internal teams are overwhelmed by the complexity of monitoring and managing a growing portfolio of AI products and agents.